Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2100 participants.

Also called NCT07190690

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07190690
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07190690. Randomized; no masking; primary purpose treatment. Start 2025-12-19 (actual); primary completion 2029-10-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
Acronym
DestinACSion
Intervention (Device)
ihtDEStiny® DES implanted
Intervention (Device)
Xience™ DES implanted
Lead sponsor
Fundación EPIC (class: other)

Record details

Record id
cardio:ct-nct07190690
Content hash
21e660aae68d0e2ab1c090d5f33b81ac79b59d9d077798633695b11257f456ac